ConductScience.org, home

Paper40051981

Comparative analysis of anthelmintic treatments: impact on liver biomarkers and clinical recovery in sheep with fasciolosis.

Gedefaw T and 3 others. Front Vet Sci, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Comparative analysis of anthelmintic treatments: impact on liver biomarkers and clinical recovery in sheep with fasciolosis. Papers, record 40051981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40051981

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative analysis of anthelmintic treatments: impact on liver biomarkers and clinical recovery in sheep with fasciolosis.
PubMed
Journal
Front Vet Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-03-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gedefaw TTameru
2Mebratu ASAtsede Solomon
3Dagnachew SShimels
4Fenta MDMelkie Dagnaw

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15119775The biochemical mode of action of the fasciolicides nitroxynil, hexachlorophane and oxyclozanide.Biochem J1971https://conductscience.org/library/papers/5119775PubMed
215110408Faecal egg count reduction test for assessing anthelmintic efficacy: average versus individually based estimations.Vet Parasitol2004https://conductscience.org/library/papers/15110408PubMed
323644385Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis.Clin Gastroenterol Hepatol2013https://conductscience.org/library/papers/23644385PubMed
47571325World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine)Vet Parasitol1995https://conductscience.org/library/papers/7571325PubMed
536311678Population, biomass, and economic value of small ruminants in Ethiopia.Front Vet Sci2022https://conductscience.org/library/papers/36311678PubMed
611430684Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica.Vet Rec2001https://conductscience.org/library/papers/11430684PubMed
734696693Pathogenicity and virulence of the liver flukes Fasciola hepatica and FasciolaGigantica that cause the zoonosis Fasciolosis.Virulence2021https://conductscience.org/library/papers/34696693PubMed
821093156Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.Vet Parasitol2011https://conductscience.org/library/papers/21093156PubMed
94277750Uncoupling activity of the anthelmintic oxyclozanide in rodents.Br J Pharmacol1974https://conductscience.org/library/papers/4277750PubMed
1016174415Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.Parasitology2005https://conductscience.org/library/papers/16174415PubMed
1116489471Anthelmintic resistance in trichostrongylid nematodes of sheep farms in Northwest Spain.Parasitol Res2006https://conductscience.org/library/papers/16489471PubMed
1230634022Target animal safety testing of an oral salicylanilide suspension, oxyclozanide, for the treatment of fascioliasis in bovine in China.Regul Toxicol Pharmacol2019https://conductscience.org/library/papers/30634022PubMed
1323718204Morphological identification of parasitic nematode infective larvae of small ruminants and cattle: a practical lab guide.Onderstepoort J Vet Res2013https://conductscience.org/library/papers/23718204PubMed
1433267701Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures.Expert Rev Anti Infect Ther2021https://conductscience.org/library/papers/33267701PubMed
1529970147Evaluating the effectiveness of trematocides against Fasciola gigantica and amphistomes infections in cattle, using faecal egg count reduction tests in Iringa Rural and Arumeru Districts, Tanzania.Parasit Vectors2018https://conductscience.org/library/papers/29970147PubMed
1634252386Efficacy of triclabendazole and albendazole against Fasciola spp. infection in cattle in Côte d'Ivoire: a randomised blinded trial.Acta Trop2021https://conductscience.org/library/papers/34252386PubMed
1736701396A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance.PLoS Pathog2023https://conductscience.org/library/papers/36701396PubMed
1816153316Triclabendazole: new skills to unravel an old(ish) enigma.J Helminthol2005https://conductscience.org/library/papers/16153316PubMed
1917694402Hematological and biochemical changes in organically farmed sheep naturally infected with Fasciola hepatica.Parasitol Res2007https://conductscience.org/library/papers/17694402PubMed
2024576602Development of an egg hatch assay for the detection of anthelmintic resistance to albendazole in Fasciola hepatica isolated from sheep.Vet Parasitol2014https://conductscience.org/library/papers/24576602PubMed

See all 32 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42305885Fasciolosis: Analytical approaches to post-treatment liver enzyme activity changes in cattle.Helminthologia2026https://conductscience.org/library/papers/42305885PubMed
41976042Development of an LC-MS/MS-Based Analytical Method, In Vitro Characterization, and Pharmacokinetic Study of Rafoxanide Nanosuspension in Sheep.Animals (Basel)2026https://conductscience.org/library/papers/41976042PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40051981

GET https://conductscience.org/api/papers/v1/40051981/references?page=2